Options: Hide MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amenorrhea secondary | x | x | x | ||||||||||||
Amenorrhoea | x | x | x | ||||||||||||
Endometriosis | x | x | x | ||||||||||||
Imbalance hormonal | x | x | x | ||||||||||||
Nulliparous | x | x | x | x | x | ||||||||||
Unintended pregnancy | x | x | x | x | x | ||||||||||
Uterine cancer | x | x | x | ||||||||||||
Uterine haemorrhage | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |